What is he best known for?
The fields of study he is best known for:
- Internal medicine
- Disease
- Surgery
Peter R. Gibson mainly focuses on Internal medicine, Gastroenterology, FODMAP, Irritable bowel syndrome and Food science.
His studies in Internal medicine integrate themes in fields like Placebo and Endocrinology.
His study in Gastroenterology is interdisciplinary in nature, drawing from both Crohn's disease, Disease, Ingestion and Intensive care medicine.
The concepts of his FODMAP study are interwoven with issues in Fructose, Diet Records, Intestinal absorption, Diet therapy and Ingredient.
His Irritable bowel syndrome research incorporates themes from Crossover study, Carbohydrate, Abdominal pain, Monosaccharide and Gluten.
His research in the fields of Fructan and Sugar overlaps with other disciplines such as Bran and Food composition data.
His most cited work include:
- A Diet Low in FODMAPs Reduces Symptoms of Irritable Bowel Syndrome (691 citations)
- Subcutaneous golimumab induces clinical response and remission in patients with moderate-to-severe ulcerative colitis. (540 citations)
- Gluten Causes Gastrointestinal Symptoms in Subjects Without Celiac Disease: A Double-Blind Randomized Placebo-Controlled Trial (532 citations)
What are the main themes of his work throughout his whole career to date?
Peter R. Gibson spends much of his time researching Internal medicine, Gastroenterology, Inflammatory bowel disease, Ulcerative colitis and Irritable bowel syndrome.
His Internal medicine research is multidisciplinary, incorporating perspectives in Endocrinology and Surgery.
His research integrates issues of Thiopurine methyltransferase, Faecal calprotectin, Randomized controlled trial and Placebo in his study of Gastroenterology.
In his research, MEDLINE is intimately related to Intensive care medicine, which falls under the overarching field of Inflammatory bowel disease.
His Irritable bowel syndrome research is multidisciplinary, relying on both Abdominal pain and Gluten.
He focuses mostly in the field of Disease, narrowing it down to matters related to Immunology and, in some cases, Intestinal mucosa.
He most often published in these fields:
- Internal medicine (60.00%)
- Gastroenterology (40.33%)
- Inflammatory bowel disease (24.75%)
What were the highlights of his more recent work (between 2016-2021)?
- Internal medicine (60.00%)
- Gastroenterology (40.33%)
- Inflammatory bowel disease (24.75%)
In recent papers he was focusing on the following fields of study:
His primary areas of study are Internal medicine, Gastroenterology, Inflammatory bowel disease, Irritable bowel syndrome and Crohn's disease.
Peter R. Gibson undertakes interdisciplinary study in the fields of Internal medicine and In patient through his research.
In his study, which falls under the umbrella issue of Gastroenterology, Pregnancy is strongly linked to Vedolizumab.
His work in Inflammatory bowel disease tackles topics such as Ulcerative colitis which are related to areas like Colitis, Adverse effect, Vitamin D and neurology and Calprotectin.
His study looks at the relationship between Irritable bowel syndrome and fields such as Intensive care medicine, as well as how they intersect with chemical problems.
His work deals with themes such as Odds ratio, Thiopurine methyltransferase, Surgery and Combination therapy, which intersect with Crohn's disease.
Between 2016 and 2021, his most popular works were:
- Fructan, Rather Than Gluten, Induces Symptoms in Patients With Self-Reported Non-Celiac Gluten Sensitivity. (150 citations)
- Review article: short chain fatty acids as potential therapeutic agents in human gastrointestinal and inflammatory disorders (116 citations)
- Systematic review: exercise-induced gastrointestinal syndrome - implications for health and intestinal disease (101 citations)
In his most recent research, the most cited papers focused on:
- Internal medicine
- Disease
- Surgery
His primary scientific interests are in Internal medicine, Gastroenterology, Inflammatory bowel disease, Crohn's disease and Irritable bowel syndrome.
His research in Internal medicine intersects with topics in Endocrinology and Surgery.
Peter R. Gibson combines subjects such as Nausea, Clinical endpoint and Crossover study with his study of Gastroenterology.
Within one scientific family, he focuses on topics pertaining to Ulcerative colitis under Inflammatory bowel disease, and may sometimes address concerns connected to Retrospective cohort study, Tacrolimus, Salvage therapy and Combination therapy.
He studied Crohn's disease and Physical therapy that intersect with Blinding, Psychological intervention, Clinical trial, Cognitive impairment and Sleep disorder.
His Irritable bowel syndrome research includes themes of Bloating, Abdominal pain and Intensive care medicine.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
